3-iodobenzylguanidine has been researched along with Atherosclerotic Parkinsonism in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buongiorno, MT; Compta, Y; Gaig, C; Lomeña, F; Martí, MJ; Muxi, A; Navarro-Otano, J; Tolosa, E; Valldeoriola, F | 1 |
Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nakazato, M; Nishii, R; Tamura, S; Wakamatsu, H; Yamashita, S | 1 |
Kim, YJ; Lee, PH; Yeo, SH; Yong, SW | 1 |
3 other study(ies) available for 3-iodobenzylguanidine and Atherosclerotic Parkinsonism
Article | Year |
---|---|
123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Smell; Tomography, Emission-Computed, Single-Photon; Tropanes | 2014 |
Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Cerebrovascular Circulation; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2008 |
Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Male; Mediastinum; Middle Aged; Olfaction Disorders; Parkinson Disease, Secondary; Smell; Tomography, Emission-Computed, Single-Photon | 2007 |